The way forward for Ketamine and Mood Disorders In 2019, the FDA and European Commission authorized the usage of an esketamine nasal spready beneath the brand name Spravato to treat melancholy. Having said that, as of 2021, ketamine hasn't been accredited through the FDA to treat melancholy or other psychological wellbeing disorders, and thus, the